Zimmer Introduces V2F™ Anterior Fixation System for the Treatment of Spinal Tumor and Trauma Pathology

 Zimmer Introduces V2F™ Anterior Fixation System for the Treatment of Spinal
                          Tumor and Trauma Pathology

System Incorporates Unique Locking-Cap Technology, Providing Greater
Flexibility in Screw Placement to Better Match Patient Anatomy

PR Newswire

MINNEAPOLIS, Minn., Jan. 21, 2013

MINNEAPOLIS, Minn., Jan. 21, 2013 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE:
ZMH; SIX: ZMH), a global leader in musculoskeletal health, today introduced
the Zimmer V2F Anterior Fixation System, a new implant system for the
treatment of thoracolumbar burst fractures, tumors, disc degeneration and
other pathologies of the anterior spine. The system represents Zimmer's first
lateral plate system for the spinal trauma segment.

The V2F System consists of a wide range of plates and screws designed to
better match the varying anatomy of the thoracolumbar spine. Leveraging a
proprietary technology developed by Zimmer's Trauma business, the V2F System
incorporates variable-to-fixed locking cap technology, which enables surgeons
to place screws at variable angles and to lock screw trajectory to the plate
rigidly, or semi-constrained. This flexibility to place screws with
variability of up to 15 degrees in any direction allows surgeons to avoid
critical anatomical structures and better fit the existing anatomical

"Tumor and trauma pathology of the spine can result in complex anatomical
challenges for surgeons," said Steve Healy, President of Zimmer Spine. "By
incorporating novel variable-to-fixed screw and cap technology, the Zimmer V2F
Anterior Fixation System offers surgeons greater flexibility to address the
unique anatomy of every patient through variable screw and plate placement and

Designed to facilitate efficiency without compromising control or strength,
the Zimmer V2F Anterior Fixation System features All-Through-One
Instrumentation to guide efficient screw placement and 6mm and 7mm dual-lead
screws to provide enhanced insertion speed and bone screw fixation.

About Zimmer
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs,
develops, manufactures and markets orthopaedic reconstructive, spinal and
trauma devices, dental implants, and related surgical products. Zimmer has
operations in more than 25 countries around the world and sells products in
more than 100 countries. Zimmer's 2011 sales were approximately $4.5
billion. The Company is supported by the efforts of more than 8,500 employees
worldwide. For more information, please visit our website at www.zimmer.com.

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995 based on
current expectations, estimates, forecasts and projections about the
orthopaedics industry, management's beliefs and assumptions made by
management. Forward-looking statements may be identified by the use of
forward-looking terms such as "may," "will," "expects," "believes,"
"anticipates," "plans," "estimates," "projects," "assumes," "guides,"
"targets," "forecasts," and "seeks" or the negative of such terms or other
variations on such terms or comparable terminology. These statements are not
guarantees of future performance and involve risks, uncertainties and
assumptions that could cause actual outcomes and results to differ
materially. For a list and description of such risks and uncertainties, see
our periodic reports filed with the U.S. Securities and Exchange Commission.
We disclaim any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise, except as may be set forth in our periodic reports.
Readers of this document are cautioned not to place undue reliance on these
forward-looking statements, since, while we believe the assumptions on which
the forward-looking statements are based are reasonable, there can be no
assurance that these forward-looking statements will prove to be accurate.
This cautionary statement is applicable to all forward-looking statements
contained in this document.

SOURCE Zimmer Holdings, Inc.

Website: http://www.zimmer.com
Contact: Media: Garry R. Clark, +1-574-372-4493, garry.clark@zimmer.com, or
Investors: Robert J. Marshall Jr., +1-574-371-8042, robert.marshall@zimmer.com
Press spacebar to pause and continue. Press esc to stop.